Reshuffles in the Closed-end Fund Space

CEF TIMES November 16-22: A number of changes to shareholder stakes took place this week

Szymon Idzikowski 23 November, 2011 | 1:40PM
Facebook Twitter LinkedIn

Advance Developing Markets (ADMF): City of London has increased its stake in the global emerging markets fund; the company has been gradually building its position and is currently the largest shareholder. Also Legal & General has bought its first tranche of shares of more than 3% in the fund, which makes it the fourth largest shareholder.

BlackRock Greater Europe (BRGE): The fund’s tender offer was under-subscribed with the company buying back roughly 1.5 million shares, representing 1.55% of the issued share capital. The last tender offer took place in May and resulted in the company buying back about 2.2 million shares.

CATCo Reinsurance Opps 'C' (CATC): The company has received placing commitments from institutional investors of USD 125 million in relation to the issue of new C shares. The placing price will be calculated as the NAV per C share as at November 30 plus 2%. The new shares are expected to be issued and admitted to trading on the Specialist Fund Market of the LSE on December 16. The issue of these shares forms the second closing of a wider placing of up to 400 million shares and follows the raising of almost USD 125 million in May. The fund was launched in December 2010 with an initial fund size of £100 million.

CQS Diversified GBP (CQS): Mulcaster Trustees took its stake in the hedge fund to nearly 8% from just 1%.

Dexion Absolute EURO (DABE): Blackrock has slashed its stake in the fund from 17% to 2.4%.

Dexion Equity Alternative (DEA): Ericsson Pensionstiftelse has increased its stake by over 6.5% in the hedge fund and is now the largest shareholder. Dexion currently trades at a 9% discount to its NAV, compared with its 12-month average discount of 13%.

Ingenious Media Active Capital (IMAC): Following the sale of its stake in the LoudWater private equity fund, Lloyds Banking Group has topped up its holding with over six million shares of this fund, also private equity, which trades at a discount to its NAV exceeding 60%. Lloyds currently holds a stake of over 6% here.

International Biotechnology (IBT): The Co-operative Asset Management has sold its entire stake exceeding 3.5 million shares of the biotechnology fund.

Juridica Investments (JIL): Baillie Gifford topped-up its account with an additional 2.7 million shares, taking its stake to almost 17%. Conversely Jupiter Asset Management has sold 1.1 million shares. Baillie Gifford and Jupiter are the second and third largest shareholders, respectively. Juridica Investments currently trades at a hefty discount of almost 30% to its NAV, compared with its 12-month average of 18.7%.

Throgmorton Trust (THRG): Legal & General Group has bought its first tranche of shares representing a 3.25% stake in the fund.

LoudWater (LWT): Lloyds Banking Group has sold its whole stake of over 22% of the private equity fund. Loudwater Trust has lost 34% since its inception in January 2007 and currently trades at a hefty discount which exceeds 53%.

Quindell Portfolio (QPP): Cenkos Securities has been appointed as joint broker and will work alongside Arbuthnot Securities, who have been sole brokers to Quindell Portfolio since December 2005.

West Pioneer Properties (WPR): Standard Life Investments has sold the whole of its stake of almost 9% in the Asia Pacific direct property fund. Conversely Faithful Century has increased its position by over 5%. West Pioneer Properties currently trades at a discount to its NAV exceeding 68%.

The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. The information contained within should not be a person's sole basis for making an investment decision. Please contact your financial professional before making an investment decision.

Facebook Twitter LinkedIn

About Author

Szymon Idzikowski

Szymon Idzikowski  is a closed-end fund analyst with Morningstar.

© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures